Cargando…
Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid Leukemia
Autores principales: | Sies, Katharina, Spohr, Corinna, Gründer, Albert, Todorova, Rumyana, Uhl, Franziska Maria, Huber, Julia, Zeiser, Robert, Pahl, Heike Luise, Becker, Heiko, Aumann, Konrad, Brummer, Tilman, Halbach, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746037/ https://www.ncbi.nlm.nih.gov/pubmed/31723823 http://dx.doi.org/10.1097/HS9.0000000000000184 |
Ejemplares similares
-
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
por: Spohr, Corinna, et al.
Publicado: (2021) -
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
por: Halbach, Sebastian, et al.
Publicado: (2013) -
Function, regulation and pathological roles of the Gab/DOS docking proteins
por: Wöhrle, Franziska U, et al.
Publicado: (2009) -
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
por: Langhammer, Melanie, et al.
Publicado: (2023) -
getITD for FLT3-ITD-based MRD monitoring in AML
por: Blätte, Tamara J., et al.
Publicado: (2019)